PASADENA, Calif., Jan. 28, 2021 /PRNewswire/ -- SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX.
Search
Recent Posts
See AllSpring has sprung across the U.S., and many of you are probably ready to hit the course and outdoor courts. But a recent injury may be interrupting your golf game or tennis match. If you’re hesitant o
TripleBlind, creator of the most complete and scalable solution for privacy enhancing computation, announced acceptance to present at IEEE’s 42nd International Conference on Distributed Computing Syst
The Mighty, the world's leading health community bringing the patient's voice to life across the healthcare industry, has hired Matthew Michelson, Ph.D. as President. Dr. Michelson is a pioneer in the
